Navigation Links
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
Date:9/21/2010

EAST HANOVER, N.J., Sept. 22 /PRNewswire-FirstCall/ -- Novartis Pharmaceuticals Corporation ("Novartis") (NYSE: NVS) announced today that the results of a Phase III study of SOM230 (pasireotide) showed a reduction in cortisol levels in patients with Cushing's disease, a condition in which a benign (non-cancerous) pituitary tumor causes the adrenal glands to produce excess cortisol and can be fatal(1). Results will be presented at the 14th Congress of the European Neuroendocrine Association (ENEA).

At six months, the majority of evaluable patients (91/103) experienced a reduction from baseline in urinary free cortisol (UFC) levels, the main measure of biochemical control of the disease. UFC levels were normalized in 26% of patients randomized to SOM230 900ug twice daily, meeting the primary endpoint of the study. Additionally, median UFC was reduced by 48% in both the 900ug and 600ug dose groups. After 12 months of treatment, results confirmed the durability of the effect(1).

On average, as UFC levels were reduced, clinical symptoms of Cushing's disease improved including reduction of blood pressure, total cholesterol, weight and body mass index (BMI)(1).

Cushing's disease is caused by a benign tumor in the pituitary gland that secretes adrenocorticotropic hormone (ACTH), which triggers the adrenal glands to produce excess cortisol. Cortisol is a powerful steroid hormone that regulates a broad range of physiologic functions, including metabolism and immunity(2). Cushing's disease can cause severe cardiovascular and metabolic-related illnesses or death(3),(4). There are currently no approved medicines to treat Cushing's disease(1).

"There is a critical need for a medical treatment for people with Cushing's disease because currently available options, such as surgery or radiotherapy, are ultimately not effective for many of the patients who suffer from this d
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
(Date:5/23/2013)... 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, will ... dbAccess Health Care Conference in Boston.   The ... a.m. Eastern Time / 8:20 a.m. Pacific Time.  The presentation ... website at http://www.neurocrine.com . If you ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... 2011 LifeVantage Corporation (OTCBB: LFVN), makers ... reported financial results for the fourth quarter and full ... year 2012 revenue and operating income guidance. ... Fiscal 2011 Fourth Quarter ResultsFor the fourth fiscal quarter ...
... Sept. 28, 2011 CVS/pharmacy held a grand ... Chemung, New York.  U.S. Senator Charles Schumer, U.S. ... York State Senator Thomas O,Mara and New York ... state and local officials who attended the grand ...
Cached Medicine Technology:LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance 2LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance 3LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance 4LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance 5LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance 6LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance 7LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance 8CVS/pharmacy Hosts Federal and State Officials at Grand Opening of Its New York Distribution Center 2CVS/pharmacy Hosts Federal and State Officials at Grand Opening of Its New York Distribution Center 3
(Date:5/25/2013)... Chandler, AZ (PRWEB) May 25, 2013 ... whitening service page in partnership with JD Media Surge, ... whitening methods are now available and, depending on the ... home. During a routine visit, the best method will ... whitening is performed during a visit. A special peroxide-based ...
(Date:5/25/2013)... May 25, 2013 A disorder of ... of peripheral neuropathy. According to neuropathy expert doctor Helen ... is estimated that the disorder affects almost 50% of ... arising from Diabetes. The high blood sugar levels in ... patients suffering from it usually tend to have abnormally ...
(Date:5/25/2013)... Animals make great companions for senior citizens, but elderly people ... far more likely to crash than those who never drive ... included 2,000 licensed drivers aged 70 and older. The nearly ... drove with their pet in the car. Among those ... twice as high as among those who never drove with ...
(Date:5/25/2013)... May 25, 2013 Studies from Johns ... are carrying excessive weight and their inability to get ... simply losing weight can naturally relieve many symptoms. ... improvement in sleep quality was significantly associated with overall ... study dated November 6th, 2012, researchers monitored ...
(Date:5/25/2013)... On May 20, 2013 the Sydney Morning Herald ... or plan for their eventual demise, but it is an ... Must-Do List to help people properly arrange for their last ... fact sheet.” , While not a formal document, this document ... It may include a summary of assets, debts, obtained ...
Breaking Medicine News(10 mins):Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2
... , CHICAGO, Aug. 21 Illinois U.S. Senate ... absolutely critical to achieve the dual goals of containing costs and ... Americans. , , Jackson said that health care ... to choose a national public plan that competes with the private ...
... Proposed Medicare Cuts Will Harm Seniors, Care, Place More than ... , , BLOOMINGTON, Minn., Aug. 21 ... U.S. House of Representatives, health reform bill, combined with the impact ... seniors in Minnesota requiring nursing and rehabilitative care will face total ...
... , , SEATTLE, Aug. ... years of experience, has joined Alliance Seating & Mobility ... an Assistive Technology Professional (ATP) in the Seattle, ... manual and power mobility solutions for people with severe physical ...
... Los Angeles, London, New Delhi, Singapore and Washington DC (August ... tumours could benefit from a lighter touch but from ... have created a touchy-feely robot that detects tougher tumour tissue ... a human. The technique also minimises tissue damage. Surgeons ...
... mounting public health concerns about obesity and persistent social pressures ... consistently exercise less than young men. And young black ... according to a University of Michigan study to be published ... Public Health . The study is one of the ...
... DC (August 21, 2009) Colorectal cancer (CRC) is ... Western world. Fortunately physicians today have an abundance of ... advanced cancer patients. Now the discovery of genetic biomarkers ... increasingly common. CRC affects approximately 150,000 patients ...
Cached Medicine News:Health News:U.S. Senate Candidate Cheryle Jackson: 'Public Option Critical to Real Health Care Reform' 2Health News:New Study of House Health Reform Bill: Minnesota Faces Over $654 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years 2Health News:Rehab Specialist, K.C. Clark, Joins Alliance Seating & Mobility in Washington 2Health News:Robot's gentle touch aids delicate cancer surgery 2Health News:Robot's gentle touch aids delicate cancer surgery 3Health News:Long-term exercise, healthy eating habits in young adults: U-M study 2Health News:Long-term exercise, healthy eating habits in young adults: U-M study 3Health News:New treatments offer better survival and fresh challenges in colorectal cancer 2Health News:New treatments offer better survival and fresh challenges in colorectal cancer 3
HemoSite meter can be used to measure the effects of transfusion or the treatment of deficiency states. It is fast, easy, convenient and discrete....
... test system is the worlds ... test system designed for use ... clinics, blood centers and emergency ... is designed for the point-of-care ...
... Variant hemoglobin testing system ... testing for diabetes monitoring, ... testing, hemoglobinopathy screening and ... single test. It has ...
The Advia 60 is designed to deliver powerful performance in a small package....
Medicine Products: